Cyclobenzaprine Hcl Tablet, Film Coated
Product Images NDC 85509-1001

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hcl (NDC 85509-1001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Phoenix Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (8550910013)

Label (8550910013)
Cyclobenzaprine Hydrochloride Tablets, USP 7.5 mg, film-coated oral tablets. The label shows packaging for 30 tablets, manufactured by Sun Pharmaceutical Industries Ltd. and repackaged by Phoenix RX LLC. It includes dosage strength, storage instructions, and a QR code for package insert information.*
FDA Label Image

Structure (Image)

Structure (Image)
Chemical structure diagram of Cyclobenzaprine HCL showing the core tricyclic ring system with an attached side chain containing a dimethylamino group and hydrochloride salt.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.